Global and United States Functional Dyspepsia Drug Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

Market Analysis and Insights: Global and United States Functional Dyspepsia Drug Market
This report focuses on global and United States Functional Dyspepsia Drug market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Functional Dyspepsia Drug market size is estimated to be worth US$ 6129.6 million in 2022 and is forecast to a readjusted size of US$ 7234.2 million by 2028 with a CAGR of 2.8% during the review period. Fully considering the economic change by this health crisis, by Type, Prokinetic Drugs accounting for % of the Functional Dyspepsia Drug global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.

Global Functional Dyspepsia Drug Scope and Market Size
Functional Dyspepsia Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Functional Dyspepsia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Functional Dyspepsia Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Functional Dyspepsia Drug market is segmented into
    Prokinetic Drugs
    Gastric Antisecretory Drugs
    Others

Segment by Application, the Functional Dyspepsia Drug market is segmented into
    Hospitals
    Drugstores

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Functional Dyspepsia Drug Market Share Analysis
Functional Dyspepsia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Functional Dyspepsia Drug business, the date to enter into the Functional Dyspepsia Drug market, Functional Dyspepsia Drug product introduction, recent developments, etc.

The major vendors covered:
    Bayer
    Sumitomo
    Cadila Pharmaceuticals
    Teva
    Johnson & Johnson
    Pfizer
    Sanofi
    AstraZeneca
    Jiangsu Aosaikang Pharma
    Eisai
    Kyowa Kirin Pharmaceuticals
    Hanmi Pharm

 1 Study Coverage
    1.1 Functional Dyspepsia Drug Product Introduction
    1.2 Global Functional Dyspepsia Drug Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Functional Dyspepsia Drug Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Functional Dyspepsia Drug Sales in Volume for the Year 2017-2028
    1.3 United States Functional Dyspepsia Drug Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Functional Dyspepsia Drug Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Functional Dyspepsia Drug Sales in Volume for the Year 2017-2028
    1.4 Functional Dyspepsia Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Functional Dyspepsia Drug in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Functional Dyspepsia Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Functional Dyspepsia Drug Market Dynamics
        1.5.1 Functional Dyspepsia Drug Industry Trends
        1.5.2 Functional Dyspepsia Drug Market Drivers
        1.5.3 Functional Dyspepsia Drug Market Challenges
        1.5.4 Functional Dyspepsia Drug Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Functional Dyspepsia Drug Market Segment by Type
        2.1.1 Prokinetic Drugs
        2.1.2 Gastric Antisecretory Drugs
        2.1.3 Others
    2.2 Global Functional Dyspepsia Drug Market Size by Type
        2.2.1 Global Functional Dyspepsia Drug Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Functional Dyspepsia Drug Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Functional Dyspepsia Drug Market Size by Type
        2.3.1 United States Functional Dyspepsia Drug Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Functional Dyspepsia Drug Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Functional Dyspepsia Drug Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Drugstores
    3.2 Global Functional Dyspepsia Drug Market Size by Application
        3.2.1 Global Functional Dyspepsia Drug Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Functional Dyspepsia Drug Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Functional Dyspepsia Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Functional Dyspepsia Drug Market Size by Application
        3.3.1 United States Functional Dyspepsia Drug Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Functional Dyspepsia Drug Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Functional Dyspepsia Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Functional Dyspepsia Drug Competitor Landscape by Company
    4.1 Global Functional Dyspepsia Drug Market Size by Company
        4.1.1 Top Global Functional Dyspepsia Drug Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Functional Dyspepsia Drug Revenue by Manufacturer (2017-2022)
        4.1.3 Global Functional Dyspepsia Drug Sales by Manufacturer (2017-2022)
        4.1.4 Global Functional Dyspepsia Drug Price by Manufacturer (2017-2022)
    4.2 Global Functional Dyspepsia Drug Concentration Ratio (CR)
        4.2.1 Functional Dyspepsia Drug Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Functional Dyspepsia Drug in 2021
        4.2.3 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Functional Dyspepsia Drug Manufacturing Base Distribution, Product Type
        4.3.1 Global Functional Dyspepsia Drug Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Functional Dyspepsia Drug Product Type
        4.3.3 Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Functional Dyspepsia Drug Market Size by Company
        4.5.1 Top Functional Dyspepsia Drug Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Functional Dyspepsia Drug Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Functional Dyspepsia Drug Sales by Players (2020, 2021 & 2022)

 5 Global Functional Dyspepsia Drug Market Size by Region
    5.1 Global Functional Dyspepsia Drug Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Functional Dyspepsia Drug Market Size in Volume by Region (2017-2028)
        5.2.1 Global Functional Dyspepsia Drug Sales in Volume by Region: 2017-2022
        5.2.2 Global Functional Dyspepsia Drug Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Functional Dyspepsia Drug Market Size in Value by Region (2017-2028)
        5.3.1 Global Functional Dyspepsia Drug Sales in Value by Region: 2017-2022
        5.3.2 Global Functional Dyspepsia Drug Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Functional Dyspepsia Drug Market Size YoY Growth 2017-2028
        6.1.2 North America Functional Dyspepsia Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Functional Dyspepsia Drug Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Functional Dyspepsia Drug Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Functional Dyspepsia Drug Market Size YoY Growth 2017-2028
        6.3.2 Europe Functional Dyspepsia Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Functional Dyspepsia Drug Market Size YoY Growth 2017-2028
        6.4.2 Latin America Functional Dyspepsia Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Functional Dyspepsia Drug Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Corporation Information
        7.1.2 Bayer Description and Business Overview
        7.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Bayer Functional Dyspepsia Drug Products Offered
        7.1.5 Bayer Recent Development
    7.2 Sumitomo
        7.2.1 Sumitomo Corporation Information
        7.2.2 Sumitomo Description and Business Overview
        7.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Sumitomo Functional Dyspepsia Drug Products Offered
        7.2.5 Sumitomo Recent Development
    7.3 Cadila Pharmaceuticals
        7.3.1 Cadila Pharmaceuticals Corporation Information
        7.3.2 Cadila Pharmaceuticals Description and Business Overview
        7.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Products Offered
        7.3.5 Cadila Pharmaceuticals Recent Development
    7.4 Teva
        7.4.1 Teva Corporation Information
        7.4.2 Teva Description and Business Overview
        7.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Teva Functional Dyspepsia Drug Products Offered
        7.4.5 Teva Recent Development
    7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Corporation Information
        7.5.2 Johnson & Johnson Description and Business Overview
        7.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Johnson & Johnson Functional Dyspepsia Drug Products Offered
        7.5.5 Johnson & Johnson Recent Development
    7.6 Pfizer
        7.6.1 Pfizer Corporation Information
        7.6.2 Pfizer Description and Business Overview
        7.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Pfizer Functional Dyspepsia Drug Products Offered
        7.6.5 Pfizer Recent Development
    7.7 Sanofi
        7.7.1 Sanofi Corporation Information
        7.7.2 Sanofi Description and Business Overview
        7.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Sanofi Functional Dyspepsia Drug Products Offered
        7.7.5 Sanofi Recent Development
    7.8 AstraZeneca
        7.8.1 AstraZeneca Corporation Information
        7.8.2 AstraZeneca Description and Business Overview
        7.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 AstraZeneca Functional Dyspepsia Drug Products Offered
        7.8.5 AstraZeneca Recent Development
    7.9 Jiangsu Aosaikang Pharma
        7.9.1 Jiangsu Aosaikang Pharma Corporation Information
        7.9.2 Jiangsu Aosaikang Pharma Description and Business Overview
        7.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Products Offered
        7.9.5 Jiangsu Aosaikang Pharma Recent Development
    7.10 Eisai
        7.10.1 Eisai Corporation Information
        7.10.2 Eisai Description and Business Overview
        7.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Eisai Functional Dyspepsia Drug Products Offered
        7.10.5 Eisai Recent Development
    7.11 Kyowa Kirin Pharmaceuticals
        7.11.1 Kyowa Kirin Pharmaceuticals Corporation Information
        7.11.2 Kyowa Kirin Pharmaceuticals Description and Business Overview
        7.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Products Offered
        7.11.5 Kyowa Kirin Pharmaceuticals Recent Development
    7.12 Hanmi Pharm
        7.12.1 Hanmi Pharm Corporation Information
        7.12.2 Hanmi Pharm Description and Business Overview
        7.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Hanmi Pharm Products Offered
        7.12.5 Hanmi Pharm Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Functional Dyspepsia Drug Industry Chain Analysis
    8.2 Functional Dyspepsia Drug Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Functional Dyspepsia Drug Distributors
    8.3 Functional Dyspepsia Drug Production Mode & Process
    8.4 Functional Dyspepsia Drug Sales and Marketing
        8.4.1 Functional Dyspepsia Drug Sales Channels
        8.4.2 Functional Dyspepsia Drug Distributors
    8.5 Functional Dyspepsia Drug Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Functional Dyspepsia Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Functional Dyspepsia Drug Market Trends
    Table 3. Functional Dyspepsia Drug Market Drivers
    Table 4. Functional Dyspepsia Drug Market Challenges
    Table 5. Functional Dyspepsia Drug Market Restraints
    Table 6. Global Functional Dyspepsia Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Functional Dyspepsia Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Functional Dyspepsia Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Functional Dyspepsia Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Functional Dyspepsia Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Functional Dyspepsia Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Functional Dyspepsia Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Functional Dyspepsia Drug Sales by Manufacturer, (M Units), 2017-2022
    Table 14. Global Functional Dyspepsia Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Functional Dyspepsia Drug Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Functional Dyspepsia Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Dyspepsia Drug as of 2021)
    Table 18. Top Players of Functional Dyspepsia Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Functional Dyspepsia Drug Product Type
    Table 20. Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Functional Dyspepsia Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Functional Dyspepsia Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Functional Dyspepsia Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Functional Dyspepsia Drug Sales by Players, (M Units), 2020, 2021 & 2022
    Table 26. United States Functional Dyspepsia Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Functional Dyspepsia Drug Sales in Volume by Region (2017-2022) & (M Units)
    Table 29. Global Functional Dyspepsia Drug Sales in Volume Forecast by Region (2023-2028) & (M Units)
    Table 30. Global Functional Dyspepsia Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Functional Dyspepsia Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Functional Dyspepsia Drug Sales in Volume by Country (2017-2028) & (M Units)
    Table 33. North America Functional Dyspepsia Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Functional Dyspepsia Drug Sales in Volume by Region (2017-2028) & (M Units)
    Table 35. Asia Pacific Functional Dyspepsia Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Functional Dyspepsia Drug Sales in Volume by Country (2017-2028) & (M Units)
    Table 37. Europe Functional Dyspepsia Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Functional Dyspepsia Drug Sales in Volume by Country (2017-2028) & (M Units)
    Table 39. Latin Americaa Functional Dyspepsia Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Functional Dyspepsia Drug Sales in Volume by Country (2017-2028) & (M Units)
    Table 41. Middle East and Africa Functional Dyspepsia Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bayer Corporation Information
    Table 43. Bayer Description and Business Overview
    Table 44. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Bayer Functional Dyspepsia Drug Product
    Table 46. Bayer Recent Development
    Table 47. Sumitomo Corporation Information
    Table 48. Sumitomo Description and Business Overview
    Table 49. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Sumitomo Product
    Table 51. Sumitomo Recent Development
    Table 52. Cadila Pharmaceuticals Corporation Information
    Table 53. Cadila Pharmaceuticals Description and Business Overview
    Table 54. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Cadila Pharmaceuticals Product
    Table 56. Cadila Pharmaceuticals Recent Development
    Table 57. Teva Corporation Information
    Table 58. Teva Description and Business Overview
    Table 59. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Teva Product
    Table 61. Teva Recent Development
    Table 62. Johnson & Johnson Corporation Information
    Table 63. Johnson & Johnson Description and Business Overview
    Table 64. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Johnson & Johnson Product
    Table 66. Johnson & Johnson Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Sanofi Corporation Information
    Table 73. Sanofi Description and Business Overview
    Table 74. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Sanofi Product
    Table 76. Sanofi Recent Development
    Table 77. AstraZeneca Corporation Information
    Table 78. AstraZeneca Description and Business Overview
    Table 79. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. AstraZeneca Product
    Table 81. AstraZeneca Recent Development
    Table 82. Jiangsu Aosaikang Pharma Corporation Information
    Table 83. Jiangsu Aosaikang Pharma Description and Business Overview
    Table 84. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Jiangsu Aosaikang Pharma Product
    Table 86. Jiangsu Aosaikang Pharma Recent Development
    Table 87. Eisai Corporation Information
    Table 88. Eisai Description and Business Overview
    Table 89. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Eisai Product
    Table 91. Eisai Recent Development
    Table 92. Kyowa Kirin Pharmaceuticals Corporation Information
    Table 93. Kyowa Kirin Pharmaceuticals Description and Business Overview
    Table 94. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Kyowa Kirin Pharmaceuticals Product
    Table 96. Kyowa Kirin Pharmaceuticals Recent Development
    Table 97. Hanmi Pharm Corporation Information
    Table 98. Hanmi Pharm Description and Business Overview
    Table 99. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Hanmi Pharm Product
    Table 101. Hanmi Pharm Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Functional Dyspepsia Drug Customers List
    Table 105. Functional Dyspepsia Drug Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Functional Dyspepsia Drug Product Picture
    Figure 2. Global Functional Dyspepsia Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Functional Dyspepsia Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Functional Dyspepsia Drug Sales 2017-2028 (M Units)
    Figure 5. United States Functional Dyspepsia Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Functional Dyspepsia Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Functional Dyspepsia Drug Sales 2017-2028 (M Units)
    Figure 8. United States Functional Dyspepsia Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Functional Dyspepsia Drug Market Share in Global, in Volume (M Units) 2017-2028
    Figure 10. Functional Dyspepsia Drug Report Years Considered
    Figure 11. Product Picture of Prokinetic Drugs
    Figure 12. Product Picture of Gastric Antisecretory Drugs
    Figure 13. Product Picture of Others
    Figure 14. Global Functional Dyspepsia Drug Market Share by Type in 2022 & 2028
    Figure 15. Global Functional Dyspepsia Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Functional Dyspepsia Drug Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Functional Dyspepsia Drug Sales by Type (2017-2028) & (M Units)
    Figure 18. Global Functional Dyspepsia Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Functional Dyspepsia Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Functional Dyspepsia Drug Market Share by Type in 2022 & 2028
    Figure 21. United States Functional Dyspepsia Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Functional Dyspepsia Drug Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Functional Dyspepsia Drug Sales by Type (2017-2028) & (M Units)
    Figure 24. United States Functional Dyspepsia Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Functional Dyspepsia Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Drugstores
    Figure 28. Global Functional Dyspepsia Drug Market Share by Application in 2022 & 2028
    Figure 29. Global Functional Dyspepsia Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Functional Dyspepsia Drug Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Functional Dyspepsia Drug Sales by Application (2017-2028) & (M Units)
    Figure 32. Global Functional Dyspepsia Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Functional Dyspepsia Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Functional Dyspepsia Drug Market Share by Application in 2022 & 2028
    Figure 35. United States Functional Dyspepsia Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Functional Dyspepsia Drug Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Functional Dyspepsia Drug Sales by Application (2017-2028) & (M Units)
    Figure 38. United States Functional Dyspepsia Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Functional Dyspepsia Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Functional Dyspepsia Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 41. North America Functional Dyspepsia Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Functional Dyspepsia Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 45. Europe Functional Dyspepsia Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Functional Dyspepsia Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 52. Asia-Pacific Functional Dyspepsia Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Functional Dyspepsia Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 64. Latin America Functional Dyspepsia Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Functional Dyspepsia Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 69. Middle East & Africa Functional Dyspepsia Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Functional Dyspepsia Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Functional Dyspepsia Drug Value Chain
    Figure 74. Functional Dyspepsia Drug Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

Market Analysis and Insights: Global and United States Functional Dyspepsia Drug Market
This report focuses on global and United States Functional Dyspepsia Drug market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Functional Dyspepsia Drug market size is estimated to be worth US$ 6129.6 million in 2022 and is forecast to a readjusted size of US$ 7234.2 million by 2028 with a CAGR of 2.8% during the review period. Fully considering the economic change by this health crisis, by Type, Prokinetic Drugs accounting for % of the Functional Dyspepsia Drug global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.

Global Functional Dyspepsia Drug Scope and Market Size
Functional Dyspepsia Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Functional Dyspepsia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Functional Dyspepsia Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Functional Dyspepsia Drug market is segmented into
    Prokinetic Drugs
    Gastric Antisecretory Drugs
    Others

Segment by Application, the Functional Dyspepsia Drug market is segmented into
    Hospitals
    Drugstores

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Functional Dyspepsia Drug Market Share Analysis
Functional Dyspepsia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Functional Dyspepsia Drug business, the date to enter into the Functional Dyspepsia Drug market, Functional Dyspepsia Drug product introduction, recent developments, etc.

The major vendors covered:
    Bayer
    Sumitomo
    Cadila Pharmaceuticals
    Teva
    Johnson & Johnson
    Pfizer
    Sanofi
    AstraZeneca
    Jiangsu Aosaikang Pharma
    Eisai
    Kyowa Kirin Pharmaceuticals
    Hanmi Pharm